CIRCULOGENE Announces Appointment of Bob Gasparini to Board of Directors
BIRMINGHAM, Ala. and Pensacola, Fla. (December 8, 2022) – CIRCULOGENE is an innovative liquid biopsy company transforming precision…
CIRCULOGENE shares results of remarkable rectal cancer study
FOR IMMEDIATE RELEASE CIRCULOGENE shares results of remarkable rectal cancer study Identifying mismatch repair-deficient (MMRd)…
CIRCULOGENE presented plasma PD-L1 data at the American Society for Radiation Oncology (ASTRO) / American Society of Clinical Oncology (ASCO) Multidisciplinary Thoracic Cancers Symposium
FOR IMMEDIATE RELEASE CIRCULOGENE presented plasma PD-L1 data at the American Society for Radiation Oncology (ASTRO)…
CIRCULOGENE Announces Lab Expansion in Florida
FOR IMMEDIATE RELEASE CIRCULOGENE Announces Lab Expansion in Florida Liquid Biopsy Company Laboratory Operations Are…
CIRCULOGENE Announces Issuance of U.S. Patent for Method of Preparing Cell-Free Nucleic Acid Molecules by In Situ Amplification
Issued patent recognizes CIRCULOGENE’s novel method of enriching cfDNA without DNA isolation, extraction or purification,…
Biological Fragmentation of Circulating Cell-free DNA Alters Genetic Representation
Current Trends in Clinical & Medical Sciences Chen Hsiung Yeh* Circulogene Theranostics, Birmingham, USA Received Date: January…
CIRCULOGENE – Subcontractor to U.S. Department of Defense Research Award – to Develop Liquid Biopsy Markers for Traumatic Brain Injury
$1.5 Million grant to The Geneva Foundation will use CIRCULOGENE’s liquid biopsy to quickly ID…
CIRCULOGENE Molecular Diagnostics Laboratory Receives College of American Pathologists (CAP) Accreditation
BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through personalized molecular genetics testing, announced today that its…